OLMESARTAN/AMLODIPINE/HYDROCHLOROTHIAZIDE (Sevikar HCT)
Clinical Indication
Non-adherence due to polypharmacy
Date of classification
March 2017
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.